Creative Planning’s Achieve Life Sciences ACHV Stock Holding History

Creative Planning’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-9	Closed	-$7K	–	1895
2017 Q2	$7K	Hold	9	–	–	﹤0.01%	3801
2017 Q1	$9K	Hold	9	–	–	﹤0.01%	3633
2016 Q4	$10K	Hold	9	–	–	﹤0.01%	3534
2016 Q3	$10K	Hold	9	–	–	﹤0.01%	3494
2016 Q2	$20K	Hold	9	–	–	﹤0.01%	2786
2016 Q1	$14K	Sell	9 -5	-36%	-$8.15K	﹤0.01%	2995
2015 Q4	$36K	Buy	+14	New	+$59.2K	﹤0.01%	2384
2015 Q3	–	Hold	0	–	–	–	3909

Other funds holding ACHV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Creative Planning's ACHV Position: Q3 2017 in Review

Creative Planning sold out of Achieve Life Sciences (ACHV) in Q3 2017, closing a stake of 9 shares — an estimated $7K sold.

Creative Planning first reported a position in ACHV in Q4 2015 and held it in 7 quarters. The position peaked at $36K in Q4 2015. 15 funds tracked by Wall St. Rank hold ACHV as of Q3 2017.

Creative Planning reported no remaining Achieve Life Sciences position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 9 Achieve Life Sciences shares in Q3 2017, an estimated $7K.
Creative Planning first reported a position in Achieve Life Sciences in Q4 2015 and held it in 7 quarters.
Creative Planning's Achieve Life Sciences position peaked at $36K in Q4 2015.
15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.